Signal Diagnostics agrees to pay $20.5M to settle COVID-19 testing overpayment claims
Signal Diagnostics LLC has agreed to pay the United States $20.5 million to resolve allegations that it violated the False Claims Act by knowingly retaining federal overpayments and improperly avoidin
1 Oct 17:00 · The Washington Times